| Enriched cancer pathway | Genes under regulation | P value |
|---|
| Neurotrophin signaling pathway |
7 genes: SH2B3, IRAK3, NTRK3, MAPK1, RAP1A, CAMK2A, RPS6KA4
|
6.529e-05 |
| Focal adhesion |
7 genes: COL1A2, COL11A1, ITGAV, PPP1R12A, MAPK1, PTEN, RAP1A
|
0.001037 |
| Long.term potentiation |
4 genes: PPP1R12A, MAPK1, RAP1A, CAMK2A
|
0.002241 |
| ECM.receptor interaction |
4 genes: COL1A2, COL11A1, ITGAV, SDC2
|
0.004521 |
| Melanogenesis |
4 genes: ADCY9, MAPK1, WNT9A, CAMK2A
|
0.00828 |
| Glycosaminoglycan biosynthesis . chondroitin sulfate |
2 genes: CHST7, XYLT1
|
0.01276 |
| ErbB signaling pathway |
3 genes: CDKN1A, MAPK1, CAMK2A
|
0.03115 |
| Hippo signaling pathway |
4 genes: LATS1, DLG2, SMAD7, WNT9A
|
0.03332 |
| GnRH signaling pathway |
3 genes: ADCY9, MAPK1, CAMK2A
|
0.04529 |
| Pancreatic secretion |
3 genes: ADCY9, ATP2B4, RAP1A
|
0.04529 |